SCHEMBL4648885

SCHEMBL4648885

COC(=O)CNC(=O)c1c(O)c2ccccc2n(C)c1=O.COc1c(C(=O)NCC(=O)O)c(=O)n(C)c2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
NPC1 O15118 1/20 0.60
RAB9A P51151 1/20 0.60
HIF1A Q16665 12/20 0.59
KDM4E B2RXH2 1/20 0.57
TSHR P16473 1/20 0.56
EGLN1 Q9GZT9 2/20 0.56
L3MBTL1 Q9Y468 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2386055 0.91 KDM4E (0.52) MEN1KMT2ANPC1RAB9AHIF1A
SCHEMBL2384674 0.91 EGFR (0.62) MEN1KMT2ANPC1RAB9AHIF1A
SCHEMBL2384134 0.89 KMT2A (0.70) MEN1KMT2ANPC1RAB9AHIF1A
SCHEMBL2399702 0.87 MEN1 (0.77) MEN1KMT2ANPC1RAB9AHIF1A
SCHEMBL12254566 0.82 KDM4E (0.52) MEN1KMT2ANPC1RAB9AHIF1A
SCHEMBL2382180 0.79 KDM4E (0.69) MEN1KMT2AKDM4ETSHREGLN1
SCHEMBL2386048 0.78 HIF1A (0.62) MEN1KMT2ANPC1RAB9AHIF1A
SCHEMBL12254380 0.78 KMT2A (0.73) MEN1KMT2ANPC1RAB9AKDM4E
SCHEMBL15859729 0.77 EGLN1 (0.69) MEN1KMT2ANPC1RAB9AHIF1A
SCHEMBL2395649 0.77 KMT2A (0.71) MEN1KMT2ANPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1960363-A2 QUINOLONE BASED COMPOUNDS EXHIBITING PROLYL HYDROXYLASE INHIBITORY ACTIVITY, AND COMPOSITIONS, AND USES THEREOF Amgen, Inc. (US) 2008-08-27 EP disclosed
WO-2007070359-A2 QUINOLONE BASED COMPOUNDS EXHIBITING PROLYL HYDROXYLASE INHIBITORY ACTIVITY, AND COMPOSITIONS, AND USES THEREOF AMGEN INC. (US) 2007-06-21 WO disclosed